Current market catalysts

Bitcoin, Ether, Hyperliquid Is Pulling In ETF Cash. Solana Is Showing Where the Risk Is Going

Bitcoin ETFs are seeing sustained inflows, but fresh demand for Solana and other crypto ETFs may reveal where institutional appetite is heading next.

TD Cowen Maintains Hold on Workday, Lowers Price Target to $210

TD Cowen analyst Derrick Wood maintains Workday (NASDAQ:WDAY) with a Hold and lowers the price target from $220 to $210.

McDonald's Stock Bounces Off Two-Year Low: What's Going On?

McDonald's shares are climbing on Friday, sitting just above its 52-week low as the chart remains under pressure even with today's move.

Barclays Maintains Overweight on RadNet, Raises Price Target to $79

Barclays analyst Andrew Mok maintains RadNet (NASDAQ:RDNT) with a Overweight and raises the price target from $65 to $79.

Nvidia Stock at Crossroads: Expert Says Shares ‘Could Double’ or AI Bubble Could Pop

A former hedge fund manager sees two extremes for Nvidia stock. The stock could double or the AI bubble could burst and hurt shares.

SoFi Stock Edges Lower Friday: What's Going On?

Shares of SoFi Technologies are dipping slightly Friday, pausing after a 13% monthly surge driven by product growth and crypto tailwinds.

Barclays Maintains Overweight on Lumexa Imaging Hldgs, Raises Price Target to $13

Barclays analyst Andrew Mok maintains Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight and raises the price target from $9 to $13.

Northland Capital Markets Maintains Outperform on Everpure, Raises Price Target to $128

Northland Capital Markets analyst Nehal Chokshi maintains Everpure (NYSE:P) with a Outperform and raises the price target from $90 to $128.

Rivian Automotive shares are trading lower the company announced that CFO Claire McDonough has decided to step down.

Northland Capital Markets Upgrades Evolution Petroleum to Outperform, Announces $4 Price Target

Northland Capital Markets analyst Jeff Grampp upgrades Evolution Petroleum (AMEX:EPM) from Market Perform to Outperform and announces $4 price target.

8-K filing — CVC-PE Global Private Equity Fund, LP

Filed: 2026-08-28 AccNo: 0001193125-26-372823 Size: 187 KB Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events

Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Raises Price Target to $15

Barclays analyst Andrew Mok maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight and raises the price target from $9.5 to $15.

CORRECTION: Spotify Technology Announced It Approved An Increase In Its Share Repurchase Program By An Additional $1.5B On Aug. 20, 2026

Lucas GC shares are trading lower after the company announced a 125-for-1 share consolidation, effective September 1.

Spotify Technology shares are trading higher after the company approved an increase in its share repurchase program.

Here's How Much $1000 Invested In Middleby 20 Years Ago Would Be Worth Today

Middleby (NASDAQ:MIDD) has outperformed the market over the past 20 years by 3.27% on an annualized basis producing an average annual return of 12.51%. Currently, Middleby has a market capitalization of $5.16 billion.

Barclays Maintains Overweight on Affirm Holdings, Raises Price Target to $105

Barclays analyst Nik Cremo maintains Affirm Holdings (NASDAQ:AFRM) with a Overweight and raises the price target from $97 to $105.

Fed Funds Futures Now Price A September Rate Hike As More Likely Than A Hold

https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html

RBC Capital Maintains Outperform on Workday, Raises Price Target to $240

RBC Capital analyst Rishi Jaluria maintains Workday (NASDAQ:WDAY) with a Outperform and raises the price target from $220 to $240.

Antelope Enterprise shares are trading lower after the company announced $18.99 million private placement of 15 million Class A ordinary shares at $1.266 per share.

Warsh Says Inflation Too High: 2% Is a 'Firm, Fixed Target' (UPDATED)

Fed Chairman Kevin Warsh says PCE inflation at 3.7% makes prices the Fed's predominant focus, and won't call financial conditions restrictive.

8-K filing — Cycurion, Inc. (CYCUW)

Filed: 2026-08-28 AccNo: 0001628280-26-059330 Size: 220 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

N-able shares are trading higher after the company announced that its Board of Directors has approved an increase of $50 million to the previously authorized share repurchase program.

RBC Capital Maintains Outperform on Standard Nuclear, Raises Price Target to $13

RBC Capital analyst Christopher Dendrinos maintains Standard Nuclear (NYSE:STDN) with a Outperform and raises the price target from $11 to $13.

JP Morgan Maintains Overweight on Affirm Holdings, Raises Price Target to $105

JP Morgan analyst Connor Allen maintains Affirm Holdings (NASDAQ:AFRM) with a Overweight and raises the price target from $90 to $105.

Microsoft Runs On It, Nvidia Validates It: IREN CEO Says the Real Edge Is Owning the Entire AI Stack

Microsoft and Nvidia milestones reinforce IREN's strategy of owning the full AI infrastructure stack, CEO Daniel Roberts says.

JP Morgan Maintains Overweight on Elastic, Raises Price Target to $105

JP Morgan analyst Brian Essex maintains Elastic (NYSE:ESTC) with a Overweight and raises the price target from $93 to $105.

8-K filing — NORTHPOINTE BANCSHARES INC (NPB)

Filed: 2026-08-28 AccNo: 0001336706-26-000068 Size: 404 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

CRISPR Therapeutics Data From Its Phase 1 Clinical Study Of CTX Shows 79% Mean Reductions From Baseline For ANGPTL3, 48% Maximum For Triglycerides

CRISPR Therapeutics (NASDAQ:CRSP) today presented durability data from its Phase 1a clinical trial evaluating CTX310®, an investigational, in vivo CRISPR/Cas9 gene editing therapy targeting ANGPTL3. A single-course

Trading Halt: Halt status updated at 10:35:00 AM ET: Quotation Resumption: IPO security released for quotation